ÜST KAPAK BLEFAROPLASTİ CERRAHİSİNDE ÇIKARILAN DOKU MİKTARININ CERRAHİ SONUÇLAR VE HASTA MEMNUNİYETİ ÜZERİNE ETKİSİNİN DEĞERLENDİRİLMESİ

AMAÇ: Üst kapak blefaroplasti uygulanan olgularda ekzise edilen doku miktarının cerrahi sonuçlar, iyileşme süresi, komplikasyon oranları, skar gelişimi ve hasta memnuniyeti üzerine olan etkisini araştırmak. GEREÇ ve YÖNTEM: Bu prospektif çalışmaya tamamı üst kapak blefaroplasti uygulanmış 94 hastanın 188 gözü dahil edildi. İntraoperatif olarak eksize edilen doku miktarı kaydedilerek cilt, cilt/kas, cilt yağ ve cilt/kas/yağ dokusu olarak sınıflandırıldı. Hastalar cerrahi sonuçlar, komplikasyon gelişimi, skar gelişimi ve iyileşme süresi açısından değerlendirildi. Postoperatif 3. ayda, hastalara cerrahi memnuniyet anketi ile birlikte, hastaların yaşam kalitesindeki değişimi, cerrahi yarar algısını ve bu değişimin özelliklerini belirlemek için Glasgow Yarar Envanter (GYE) anketi uygulandı. Eksize edilen doku miktarı ile iyileşme süresi, komplikasyon gelişimi, skar gelişimi ,GYE skoru ve cerrahiden memnuniyet düzeyi arasındaki ilişki araştırıldı. BULGULAR: Yaş ortalaması 55,2 ±7,6 yıl olup, hastaların % 78,7’si kadındı. Hastaların 19’una yalnızca cilt eksizyonu, 38’ine cilt ve kas eksizyonu, 7’sine cilt ve yağ eksizyonu, ve 30’una ise cilt, kas ve yağ eksizyonu uygulanmıştı. Hastaların %81.9’u geçirdikleri cerrahiden çok memnun olduğunu, %11,7’si memnun olduğunu, %5,3’ü orta düzeyde memnun olduğunu ve %1,1’i memnun olmadığını ifade etti. GYE anket sonucuna göre, hem total GYE skorunda hem de alt skorlarda artış saptandı. Eksize edilen doku miktarı ile cerrahi sonuçlar, iyileşme süresi, skar oluşumu, komplikasyon oranları, hasta memnuniyeti ve GYE skoru arasında anlamlı bir fark yoktu (p>0,05). SONUÇ: Üst kapak blefaroplasti cerrahisinden sonra, eksize edilen doku miktarından bağımsız olarak, hastaların büyük kısmında fonksiyonel iyileşme ile birlikte hasta memnuniyetinde ve cerrahi yarar algısında artış meydana gelmiştir.

Anahtar Kelimeler:

Kelimeler: dermatoşalazis, blefaroplasti, hasta memnuniyeti, Glasgow Fayda Envanteri

EVALUATION OF THE EFFECT OF REMOVED TISSUE IN UPPER BLEPHAROPLASTY ON SURGICAL OUTCOMES AND PATIENT SATISFACTION

AİM: To investigate the effect of the removed tissue on surgical results, recovery duration, complication rate, scar development, and patient satisfaction in cases in which upper blepharoplasty was performed. MATERİAL AND METHOD: This prospective study included 188 eyes of 94 patients who underwent upper blepharoplasty. The removed tissue was classified as skin, skin/muscle, skin/fat, and skin/muscle/fat. The patients were evaluated in terms of surgical results, complications, scar development, and recovery duration. At the postoperative 3rd month, Glasgow Benefit Inventory (GBI) questionnaire and surgical satisfaction questionnaire were applied to determine the change in the quality of life, and the perception of surgical benefit. The relationship between the removed tissue and the recovery duration, complications, scar development, GBI score, and satisfaction with the surgery were evaluated. RESULTS: Mean age was 55.2 ±7.6 years and %78.7 of the patients were female. The nineteen of patients underwent resection of skin, 38 of the patients underwent resection of skin/muscle, 7 of the patients underwent resection of skin/fat, and 30 of the patients underwent resection of skin/muscle/fat. Of the patients, 81.9% were very satisfied with the surgery, 11.7% were satisfied, 5.3% were moderately satisfied, and 1.1% were dissatisfied. An increase was detected both in total GBI scores and subscores. There was no significant difference between the removed tissue and surgical outcomes, recovery duration, scar development, complications, patient satisfaction, and GBI scores (p>0.05). CONCLUSİON: Regardless of the removed tissue, the majority of patients experienced an increase in patient satisfaction and perceived surgical benefit, along with functional improvement.

Keywords:

dermatochalasis, blepharoplasty, patient satisfaction, Glasgow Benefit Inventory,

PDF

___

1. Yang P, Ko AC, Kikkawa DO, et al. Upper eyelid blepharoplasty: Evaluation, treatment, and complication minimization. Semin Plast Surg. 2017; 31: 51-7.
2. Olds C, Most SP. Upper Blepharoplasty. JAMA. 2019; 321:1320.
3. Bhattacharjee K, Misra DK, Deori N. Updates on upper eyelid blepharoplasty. Indian J Ophthalmol. 2017; 65: 551-8.
4. Zhang SY, Yan Y, Fu Y. Cosmetic blepharoplasty and dry eye disease: a review of the incidence, clinical manifestations, mechanisms and prevention. Int J Ophthalmol. 2020; 13: 488-92.
5. Saalabian AA, Liebmann P, Deutinger M. Which tissue should be removed in upper blepharoplasty? Analysis and evaluation of satisfaction. World J Plast Surg. 2017; 6: 324-33.
6. Rohrich RJ, Coberly DM, Fagien S, et al. Current concepts in aesthetic upper blepharoplasty. Plast Reconstr Surg. 2004; 113: 32-42.
7. Hoorntje LE, Lei BV, Stollenwerck GA, et al. Resecting orbicularis oculi muscle in upper eyelid blepharoplasty--a review of the literature. J Plast Reconstr Aesthet Surg. 2010; 63: 787-92.
8. Akkaya S. Evaluation of surgical outcomes, patient satisfaction, and potential complications after blepharoplasty. Beyoglu Eye J. 2018; 3: 91-5.
9. Robinson K, Gatehouse S, Browning GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol. 1996; 105: 415-22.
10. Smith HB, Jyothi SB, Mahroo OA, et al. Patient-reported benefit from oculoplastic surgery. Eye (Lond). 2012; 26: 1418-23.
11. Papadopulos NA, Hodbod M, Henrich G, et al. The Effect of blepharoplasty on our patient's quality of life, emotional stability, and self-esteem. J Craniofac Surg. 2019; 30: 377-83.
12. Hollander MHJ, Contini M, Pott JW, et al. Functional outcomes of upper eyelid blepharoplasty: A systematic review. J Plast Reconstr Aesthet Surg. 2019; 72: 294-309.
13. Bullock JD, Warwar RE, Bienenfeld DG, et al Psychosocial implications of blepharoptosis and dermatochalasis. Trans Am Ophthalmol Soc. 2001; 99: 65-71.
14. Jacobsen AG, Brost B, Vorum H, et al. Functional benefits and patient satisfaction with upper blepharoplasty - evaluated by objective and subjective outcome measures. Acta Ophthalmol. 2017; 95: 820-5.
15. DeAngelis DD, Carter SR, Seiff SR. Dermatochalasis. Int Ophthalmol Clin. 2002; 42: 89-101.
16. Bahceci Simsek I. Association of upper eyelid ptosis repair and blepharoplasty with headache-related quality of life. JAMA Facial Plast Surg. 2017; 19: 293-7.
17. Fuller ML, Briceño CA, Nelson CC, Bradley EA. Tangent screen perimetry in the evaluation of visual field defects associated with ptosis and dermatochalasis. PLoS One. 2017; 12: e0174607.
18. Warwar RE, Bullock JD, Markert RJ, et al. Social implications of blepharoptosis and dermatochalasis. Ophthalmic Plast Reconstr Surg. 2001; 17: 234-40.
19. Bater KL, Ishii M, Nellis JC, et al A dual approach to understanding facial perception before and after blepharoplasty. JAMA Facial Plast Surg. 2018; 20: 43-9.
20. Gracitelli CPB, Osaki TH, Hirai FE, et al. Assessment of self-esteem and psychological aspects in patients undergoing upper blepharoplasty. Rev Bras Ophthalmol. 2017; 76: 280-4.
21. Damasceno RW, Cariello AJ, Cardoso EB, et al. Upper blepharoplasty with or without resection of the orbicularis oculi muscle: a randomized double-blind left-right study. Ophthalmic Plast Reconstr Surg. 2011; 27: 195-7.